Traxxec's CEO Amy Scopes comments "This is extremely positive and
up-beat news for the company providing early exposure of both the Company
and its developed product to target customers in line with our projected
For more information please visit http://www.Traxxec.com
1. Traxxec's technology has worldwide patent protection
2. As part of the proposed business model and product development
process the founders of Traxxec, funded by the pharmaceutical
industry, have undertaken through two pilot installations a
feasibility study on product design and as a consequence of this
work, supplied a fully commercial product for evaluation purposes to
a client with an annual buying capacity of 20,000,000 bottles.
Traxxec Ltd was incorporated specifically to exploit this IP
commercially. Since its incorporation, Traxxec Ltd has also supplied
commercial product for a live, current phase III study in the US. As
part of the technology transfer to Rexam Pharma, commercial product
was successfully manufactured by them and supported by systems
software provided by Traxxec Ltd. To date 21,000 units have been
3. The result of the comprehensive testing led to the decision by Rexam
to enter into licensing negotiation and complete the 15 year royalty
licence agreement. The market sector for pharmaceutical product is in
excess of 20 billion US dollars and bottles represent 30% of the
available market per annum.
For further information on Traxxec's developments within the
RFID/packaging industry please visit the articles below.
|SOURCE Traxxec Ltd.|
Copyright©2008 PR Newswire.
All rights reserved